Fecal Transplant + Diet for Aging

(ENGRAFT Trial)

SP
RS
Overseen ByRoujheen Sabetan, MPH
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Stanford University
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to test whether young-donor fecal microbiome transplantation (FMT) and a fermented, plant-rich high-fiber, microbiome rejuvenating diet (MRD) reduce inflammatory and biological aging markers. Participants (≥40 years) will be randomized (1:1:1:1) for 8 weeks with 4-week follow-up to: (A) diet alone, (B) FMT alone, (C) diet + FMT, or (D) Placebo FMT. We will use rigorously screened young and healthy FMT donors and encapsulated delivery. Outcomes include change from baseline to end of dietary intervention (week 8) in markers of aging and inflammation. Secondary outcomes include defining microbiome engraftment/diversity/function, key metabolites, diet adherence, and quality-of-life.

Are You a Good Fit for This Trial?

This trial is for adults aged 40 and older who want to help study ways to reduce signs of aging and inflammation. People with certain health conditions or on medications that could interfere with the study may not be able to join.

Inclusion Criteria

Willing to adhere to the study's lifestyle considerations for the duration of the study (maintain usual diet unless assigned to the diet arm; maintain usual physical activity; avoid non-essential systemic antibiotics; avoid probiotic/prebiotic/synbiotic supplements)
I am at least 40 years old.
In generally good health, as determined by medical history, medication review, and investigator assessment
See 3 more

Exclusion Criteria

I am currently taking medications that suppress my immune system.
I have diabetes.
I have hyperthyroidism or my hypothyroidism is not well controlled.
See 26 more

What Are the Treatments Tested in This Trial?

Interventions

  • Fecal Microbiota Transplant Capsules
  • Microbiome Rejuvenating Diet

Trial Overview

The study compares four groups: a special high-fiber, plant-based diet; capsules containing gut bacteria from young donors (fecal transplant); both the diet and fecal transplant together; or placebo capsules. Participants are randomly assigned for 8 weeks.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: FMT and Diet interventionExperimental Treatment2 Interventions
Group II: FMTExperimental Treatment1 Intervention
Group III: Placebo FMT and dietActive Control2 Interventions
Group IV: Placebo FMTPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

University of Minnesota

Collaborator

Trials
1,459
Recruited
1,623,000+